20170630 10Q Q2

UNITED STATES  

SECURITIES AND EXCHANGE COMMISSION  

Washington, D.C. 20549  

  

FORM 10-Q  

    Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934  

  

For the quarterly period ended:  June 30, 2017 or  

  

 Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934  

  

For the transition period from ________________ to ________________  

  

Commission file number:  0-25426  

  

nati-20120630x10qg1.jpg  

NATIONAL INSTRUMENTS CORPORATION  

(Exact name of registrant as specified in its charter)  



 

 

Delaware  

(State or other jurisdiction of incorporation or organization)

 

74-1871327  

(I.R.S. Employer Identification Number)



 

 

11500 North MoPac Expressway  

Austin, Texas

 

  

78759

(address of principal executive offices)

 

(zip code)

  

Registrant's telephone number, including area code:  (512) 683-0100  

_____________________

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No   

  

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  No   

  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):  

  

Large accelerated filer Accelerated filer Non-accelerated filer Smaller reporting company  Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

  

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  No   

  

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.  





 

Class

Outstanding at July  25, 2017

Common Stock - $0.01 par value

130,493,232



1


 



NATIONAL INSTRUMENTS CORPORATION  

  

INDEX  





 

 



 

 



 

 

PART I.  FINANCIAL INFORMATION 

Page No.



 

 

Item 1

Financial Statements:

 



 

 



Consolidated Balance Sheets

 



June 30, 2017 (unaudited) and December 31, 2016

3



 

 



Consolidated Statements of Income

 



(unaudited) for the three and six month periods ended June 30, 2017 and 2016

4



 

 



Consolidated Statements of Comprehensive Income

 



(unaudited) for the three and six month periods ended June 30, 2017 and 2016

5



 

 



Consolidated Statements of Cash Flows

 



(unaudited) for the six month periods ended June 30, 2017 and 2016

6



 

 



Notes to Consolidated Financial Statements

7



 

 

Item 2

Management's Discussion and Analysis of Financial Condition and Results of Operations

24



 

 

Item 3

Quantitative and Qualitative Disclosures about Market Risk

36



 

 

Item 4

Controls and Procedures

36



 

 



 

 

PART II.  OTHER INFORMATION

 



 

 



 

 

Item 1

Legal Proceedings

36



 

 

Item 1A

Risk Factors

36



 

 

Item 2

Unregistered Sales of Equity Securities and Use of Proceeds

46



 

 

Item 5

Other Information

46



 

 

Item 6

Exhibits

46



 

 



Signatures and Certifications

49



  

   

2


 

  

  

PART I - FINANCIAL INFORMATION  

  

ITEM 1.Financial Statements  

  

NATIONAL INSTRUMENTS CORPORATION  

CONSOLIDATED BALANCE SHEETS  

(in thousands, except share and per share data)  

        



 

 

 

 



 

June 30,

 

December 31,



 

2017

 

2016

Assets

 

(unaudited)

 

 

Current assets:

 

 

 

 

Cash and cash equivalents

$

263,150 

$

285,283 

Short-term investments

 

105,284 

 

73,117 

Accounts receivable, net

 

230,958 

 

228,686 

Inventories, net

 

186,155 

 

193,608 

Prepaid expenses and other current assets

 

52,568 

 

53,953 

Total current assets

 

838,115 

 

834,647 

Property and equipment, net

 

256,761 

 

260,456 

Goodwill

 

261,411 

 

253,197 

Intangible assets, net

 

120,327 

 

108,663 

Other long-term assets

 

28,700 

 

39,601 

Total assets

$

1,505,314 

$

1,496,564 

Liabilities and stockholders' equity

 

 

 

 

Current liabilities:

 

 

 

 

Accounts payable

$

54,214 

$

48,800 

Accrued compensation

 

36,672 

 

27,743 

Deferred revenue - current

 

120,212 

 

115,577 

Accrued expenses and other liabilities

 

15,341 

 

32,997 

Other taxes payable

 

28,743 

 

34,958 

Total current liabilities

 

255,182 

 

260,075 

Long-term debt

 

25,000 

 

25,000 

Deferred income taxes

 

35,561 

 

45,386 

Liability for uncertain tax positions

 

12,438 

 

11,719 

Deferred revenue - long-term

 

31,665 

 

29,752 

Other long-term liabilities

 

7,420 

 

10,413 

Total liabilities

 

367,266 

 

382,345 

Commitments and contingencies

 

 

 

 

Stockholders' equity:

 

 

 

 

Preferred stock:  par value $0.01;  5,000,000 shares authorized; none issued and outstanding 

 

 -

 

 -

Common stock:  par value $0.01;  360,000,000 shares authorized; 130,493,232 shares and 129,202,979 shares issued and outstanding, respectively 

 

1,305 

 

1,292 

Additional paid-in capital

 

800,774 

 

771,346 

Retained earnings

 

359,088 

 

376,202 

Accumulated other comprehensive loss

 

(23,119)

 

(34,621)

Total stockholders’ equity

 

1,138,048 

 

1,114,219 

Total liabilities and stockholders’ equity

$

1,505,314 

$

1,496,564 

 

The accompanying notes are an integral part of the financial statements. 

3


 

  

NATIONAL INSTRUMENTS CORPORATION  

CONSOLIDATED STATEMENTS OF INCOME  

(in thousands, except per share data)  

(unaudited)  

  

  





 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 



 

Three Months Ended

 

Six Months Ended



 

June 30,

 

June 30,



 

2017

 

2016

 

2017

 

2016



 

 

 

 

 

 

 

 

Net sales:

 

 

 

 

 

 

 

 

Product

$

289,817 

$

278,530 

$

561,328 

$

537,963 

Software maintenance

 

28,792 

 

27,575 

 

57,386 

 

55,319 

Total net sales

 

318,609 

 

306,105 

 

618,714 

 

593,282 



 

 

 

 

 

 

 

 

Cost of sales:

 

 

 

 

 

 

 

 

Product

 

79,153 

 

75,194 

 

154,349 

 

149,404 

Software maintenance

 

3,307 

 

2,314 

 

4,635 

 

4,250 

Total cost of sales

 

82,460 

 

77,508 

 

158,984 

 

153,654 



 

 

 

 

 

 

 

 

Gross profit

 

236,149 

 

228,597 

 

459,730 

 

439,628 



 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

Sales and marketing

 

124,414 

 

116,361 

 

241,674 

 

229,568 

Research and development

 

56,913 

 

59,839 

 

115,175 

 

119,179 

General and administrative

 

26,191 

 

25,130 

 

51,933 

 

49,770 

Total operating expenses

 

207,518 

 

201,330 

 

408,782 

 

398,517 



 

 

 

 

 

 

 

 

Operating income

 

28,631 

 

27,267 

 

50,948 

 

41,111 



 

 

 

 

 

 

 

 

Other income:

 

 

 

 

 

 

 

 

Interest income

 

509 

 

258 

 

852 

 

511 

Net foreign exchange gain (loss)

 

447 

 

(1,285)

 

529 

 

(711)

Other gain (loss), net

 

(235)

 

53 

 

197 

 

(2,353)

Income before income taxes

 

29,352 

 

26,293 

 

52,526 

 

38,558 

Provision for income taxes

 

4,197 

 

6,493 

 

9,223 

 

9,460 



 

 

 

 

 

 

 

 

Net income

$

25,155 

$

19,800 

$

43,303 

$

29,098 



 

 

 

 

 

 

 

 

Basic earnings per share

$

0.19 

$

0.15 

$

0.33 

$

0.23 



 

 

 

 

 

 

 

 

Weighted average shares outstanding - basic

 

130,197 

 

128,282 

 

129,820 

 

127,938 



 

 

 

 

 

 

 

 

Diluted earnings per share

$

0.19 

$

0.15 

$

0.33 

$

0.23 



 

 

 

 

 

 

 

 

Weighted average shares outstanding - diluted

 

131,117 

 

128,746 

 

130,619 

 

128,429 



 

 

 

 

 

 

 

 

Dividends declared per share

$

0.21 

$

0.20 

$

0.42 

 

0.40 



The accompanying notes are an integral part of these financial statements.

4


 

  

  

NATIONAL INSTRUMENTS CORPORATION  

 CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME  

(in thousands)  

(unaudited)  

  





 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 



 

Three Months Ended

 

Six Months Ended



 

June 30,

 

June 30,



 

2017

 

2016

 

2017

 

2016



 

 

 

 

 

 

 

 

Net income

$

25,155 

$

19,800 

$

43,303 

$

29,098 

Other comprehensive income, before tax and net of reclassification adjustments:

 

 

 

 

 

 

 

 

Foreign currency translation adjustment

 

11,702 

 

(6,191)

 

15,664 

 

8,166 

Unrealized gain on securities available-for-sale

 

34 

 

211 

 

26 

 

549 

Unrealized (loss) gain on derivative instruments

 

(3,522)

 

138 

 

(6,334)

 

3,565 

Other comprehensive (loss) gain, before tax

 

8,214 

 

(5,842)

 

9,356 

 

12,280 

Tax (benefit) expense related to items of other comprehensive income

 

(1,186)

 

(1,436)

 

(2,146)

 

3,275 

Other comprehensive (loss) gain, net of tax

 

9,400 

 

(4,406)

 

11,502 

 

9,005 

Comprehensive income

$

34,555 

$

15,394 

$

54,805 

$

38,103 



 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these financial statements.



 

5


 

  

NATIONAL INSTRUMENTS CORPORATION 

CONSOLIDATED STATEMENTS OF CASH FLOWS  

(in thousands)  

(unaudited)  

  

  





 

 

 

 



 

 

 

 



 

Six Months Ended



 

June 30,



 

2017

 

2016

Cash flow from operating activities:

 

 

 

 

Net income

$

43,303 

$

29,098 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

Depreciation and amortization

 

35,915 

 

38,217 

Stock-based compensation

 

13,726 

 

13,497 

Tax expense from deferred income taxes

 

(875)

 

(2,927)

Changes in operating assets and liabilities

 

(7,284)

 

2,659 

Net cash provided by operating activities

 

84,785 

 

80,544 



 

 

 

 

Cash flow from investing activities:

 

 

 

 

Capital expenditures

 

(15,727)

 

(20,970)

Capitalization of internally developed software

 

(24,816)

 

(15,406)

Additions to other intangibles

 

(1,124)

 

(689)

Acquisitions, net of cash received

 

 -

 

(549)

Purchases of short-term investments

 

(52,807)

 

(5,008)

Sales and maturities of short-term investments

 

21,017 

 

31,734 

Net cash used in investing activities

 

(73,457)

 

(10,888)



 

 

 

 

Cash flow from financing activities:

 

 

 

 

Proceeds from revolving line of credit

 

 -

 

15,000 

Principal payments on revolving line of credit

 

 -

 

(12,000)

Proceeds from issuance of common stock

 

15,407 

 

14,830 

Repurchase of common stock

 

 -

 

(5,635)

Dividends paid

 

(54,595)

 

(51,273)

Net cash used in financing activities

 

(39,188)

 

(39,078)



 

 

 

 

Effect of exchange rate changes on cash

 

5,727 

 

3,554 



 

 

 

 

Net change in cash and cash equivalents

 

(22,133)

 

34,132 

Cash and cash equivalents at beginning of period

 

285,283 

 

251,129 

Cash and cash equivalents at end of period

$

263,150 

$

285,261 

 

The accompanying notes are an integral part of these financial statements.  

6


 

  

NATIONAL INSTRUMENTS CORPORATION 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS  

  

Note 1 – Basis of presentation  

  

The accompanying unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended December 31, 2016, included in our annual report on Form 10-K, filed with the Securities and Exchange Commission. In our opinion, the accompanying consolidated financial statements reflect all adjustments (consisting only of normal recurring items) considered necessary to present fairly our financial position at June 30, 2017 and December 31, 2016, the results of our operations and comprehensive income for the three and six month periods ended June 30, 2017 and 2016, and the cash flows for the six month periods ended June 30, 2017 and 2016. Our operating results for the three and six month periods ended June 30, 2017 are not necessarily indicative of the results that may be expected for the year ending December 31, 2017. These financial statements have been prepared in accordance with accounting principles generally accepted in the United States.



Starting January 1, 2017, we began separately presenting the effect of exchange rate changes on cash and cash equivalents in our condensed consolidated statements of cash flows due to growing operations in foreign currency environments. Amounts in the comparable prior period have been reclassified to conform to the current period presentation.  The reclassifications resulted in the disaggregation of the amount attributable to the “Effect of exchange rate changes on cash” of $3.6 million, with a corresponding decrease to “Net cash provided by operating activities” for the six month period ended June 30, 2016. We believe the reclassification is immaterial to the consolidated financial statements.



Recently Adopted Accounting Pronouncements



In October 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-16, Income Taxes – Intra-Entity Transfers of Assets Other Than Inventory. The standard is intended to address diversity in practice and complexity in financial reporting, particularly for intra-entity transfers of intellectual property. We early adopted ASU 2016-16 effective January 1, 2017. Using the modified retrospective method, the impact of the adoption of the standard was to increase deferred tax assets by $0.4 million, decrease other assets, net by $6.2 million and decrease retained earnings by $5.8 million. The adoption of the amendments had the effect of increasing our diluted earnings per share by $0.01 and $0.02 for the three and six month periods ended June 30, 2017, respectively.



Recently Issued Accounting Pronouncements



In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which supersedes ASC840, Leases. The guidance requires lessees to recognize most lease liabilities on their balance sheets but recognize the expenses on their income statements in a manner similar to current practice. The update states that a lessee would recognize a lease liability for the obligation to make lease payments and a right-to-use asset for the right to use the underlying asset for the lease term. The update is effective for interim and annual periods beginning after December 15, 2018, and early adoption is permitted. We are currently evaluating the effect that the updated standard will have on our Consolidated Financial Statements and related disclosures. We do not expect to adopt the new standard prior to the required effective date.



In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606). The update is a comprehensive new revenue recognition model that requires a company to recognize revenue to depict the transfer of goods or services to a customer at an amount that reflects the consideration it expects to receive in exchange for those goods or services. ASU 2014-09 also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. As currently issued and amended, ASU 2014-09 is effective for annual reporting periods, and interim periods within that period, beginning after December 15, 2017 and early adoption is permitted for annual reporting periods, and interim periods within that period, beginning after December 31, 2016. We intend to adopt this standard as of January 1, 2018 by applying the modified retrospective transition method. Consequently, the cumulative effect of applying the new standard to existing contracts as of January 1, 2018 will be recognized as an adjustment to the opening balance of equity in the first quarter of 2018.



7


 

We anticipate ASU 2014-09, as amended, could have a material impact on our consolidated financial statements and disclosures. We have reached initial conclusions on our key accounting matters related to the new standard and believe adoption of the new standard will generally result in revenue recognition earlier or at the same time as existing US GAAP. The most significant impact of the standard relates to our accounting for certain software arrangements. We primarily license software on a perpetual basis. However, we also license software under enterprise agreements which includes an unlimited quantity of certain software licenses for a fixed-term bundled with software maintenance, technical support, and a specified amount of training and service credits. Currently, we defer revenue for software licensed under our enterprise agreements and certain perpetual arrangements due to a lack of vendor specific objective evidence (“VSOE”) for certain elements in the contract. Under the new standard, we are no longer required to establish VSOE to recognize software license revenue separately from the other elements, and we will be able to recognize software license revenue once the customer obtains control of the license, which will generally occur at the start of each license term. Due to the complexity of our enterprise agreement contracts, the actual revenue recognition treatment required under the new standard will be dependent on contract-specific terms, and may vary in some instances from recognition at the time of billing. Additionally, we expect the new standard will impact the way we allocate the transaction price for arrangements with separately-priced extended warranty offerings. We will continue to monitor and assess the impact of changes to the standard and interpretations as they become available.



Other Updates



The FASB also issued the following ASUs which are not expected to have a material impact on our financial condition, results of operations or cash flows upon adoption:



·

ASU 2017-11—Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception



·

ASU 2017-10—Service Concession Arrangements (Topic 853): Determining the Customer of the Operation Services (a consensus of the FASB Emerging Issues Task Force)

 

·

ASU 2017-09—Compensation—Stock Compensation (Topic 718): Scope of Modification Accounting

 

·

ASU 2017-08—Receivables—Nonrefundable Fees and Other Costs (Subtopic 310-20): Premium Amortization on Purchased Callable Debt Securities

 

·

ASU 2017-07 —Compensation—Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost

 

·

ASU 2017-06—Plan Accounting: Defined Benefit Pension Plans (Topic 960), Defined Contribution Pension Plans (Topic 962), Health and Welfare Benefit Plans (Topic 965): Employee Benefit Plan Master Trust Reporting (a consensus of the Emerging Issues Task Force)

 

·

ASU 2017-05—Other Income—Gains and Losses from the Derecognition of Nonfinancial Assets (Subtopic 610-20): Clarifying the Scope of Asset Derecognition Guidance and Accounting for Partial Sales of Nonfinancial Assets



·

ASU 2016-18—Statement of Cash Flows (Topic 230): Restricted Cash (a consensus of the FASB Emerging Issues Task Force)



  



8


 

Note 2 – Earnings per share  

  

Basic earnings per share (“EPS”) is computed by dividing net income by the weighted average number of common shares outstanding during each period. Diluted EPS is computed by dividing net income by the weighted average number of common shares and common share equivalents outstanding (if dilutive) during each period. The number of common share equivalents, which includes restricted stock units (“RSUs”), is computed using the treasury stock method.    



The reconciliation of the denominators used to calculate basic EPS and diluted EPS for the three and six month periods ended June 30, 2017 and 2016, are as follows:



 

 

 

 

 

 

 



 

 

 

 

 

 

 



Three Months Ended June 30,

 

Six Months Ended June 30,



(In thousands)

 

(In thousands)



(Unaudited)

 

(Unaudited)



2017

 

2016

 

2017

 

2016

Weighted average shares outstanding-basic

130,197 

 

128,282 

 

129,820 

 

127,938 

Plus: Common share equivalents

 

 

 

 

 

 

 

RSUs

920 

 

464 

 

799 

 

491 

Weighted average shares outstanding-diluted

131,117 

 

128,746 

 

130,619 

 

128,429 

  

Stock awards to acquire 6,800 shares and 51,000 shares for the three months ended June 30, 2017 and 2016, respectively, and 13,500 shares and 333,000 shares for the six month periods ended June 30, 2017 and 2016, respectively, were excluded in the computations of diluted EPS because the effect of including the stock awards would have been anti-dilutive.

 

 



Note 3 – Short-term investments  

  

The following tables summarize unrealized gains and losses related to our short-term investments designated as available-for-sale:



 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 



 

As of June 30, 2017

(In thousands)

 

(Unaudited)



 

 

 

Gross

 

Gross

 

Cumulative

 

 



 

Adjusted Cost

 

Unrealized Gain

 

Unrealized Loss

 

Translation Adjustment

 

Fair Value

Corporate bonds

 

92,561 

 

78 

 

(145)

 

(1,466)

 

91,028 

U.S. treasuries and agencies

 

12,496 

 

 -

 

 -

 

 -

 

12,496 

Time deposits

 

1,760 

 

-

 

 -

 

 -

 

1,760 

Short-term investments

$

106,817 

$

78 

$

(145)

$

(1,466)

$

105,284 





 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

(In thousands)

 

December 31, 2016



 

 

 

Gross

 

Gross

 

Cumulative

 

 



 

Adjusted Cost

 

Unrealized Gain

 

Unrealized Loss

 

Translation Adjustment

 

Fair Value

Corporate bonds

 

72,986 

 

89 

 

(182)

 

(1,536)

 

71,357 

Time deposits

 

1,760 

 

 -

 

 -

 

 -

 

1,760 

Short-term investments

$

74,746 

$

89 

$

(182)

$

(1,536)

$

73,117 

  

9


 

The following tables summarize the contractual maturities of our short-term investments designated as available-for-sale:



 

 

 

 



 

 

 

 



 

As of June 30, 2017

(In thousands)

 

(Unaudited)



 

Adjusted Cost

 

Fair Value

Due in less than 1 year

$

29,189 

$

29,180 

Due in 1 to 5 years

 

77,628 

 

76,104 

Total available-for-sale debt securities

$

106,817 

$

105,284 



 

 

 

 

Due in less than 1 year

 

Adjusted Cost

 

Fair Value

Corporate bonds

$

14,933 

$

14,924 

U.S. treasuries and agencies

 

12,496 

 

12,496 

Time deposits

 

1,760 

 

1,760 

Total available-for-sale debt securities

$

29,189 

$

29,180 



 

 

 

 

Due in 1 to 5 years

 

Adjusted Cost

 

Fair Value

Corporate bonds

$

77,628 

$

76,104 

Total available-for-sale debt securities

$

77,628 

$

76,104 

   

     

Note 4 – Fair value measurements 

  

We define fair value to be the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, we consider the principal or most advantageous market that market participants may use when pricing the asset or liability.   

We follow a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value measurement is determined based on the lowest level input that is significant to the fair value measurement. The three values of the fair value hierarchy are the following:   

Level 1 – Quoted prices in active markets for identical assets or liabilities   

Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly   

Level 3 – Inputs that are not based on observable market data   

Assets and liabilities measured at fair value on a recurring basis are summarized below:





 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 



 

Fair Value Measurements at Reporting Date Using

(In thousands)

 

(Unaudited)

Description

 

June 30, 2017

 

Quoted Prices in Active Markets for Identical Assets (Level 1)

 

Significant Other Observable Inputs (Level 2)

 

Significant Unobservable Inputs (Level 3)

Assets

 

 

 

 

 

 

 

 

Cash and cash equivalents available for sale:

 

 

 

 

 

 

 

 

Money Market Funds

$

15,951 

$

15,951 

$

 -

$

 -

U.S. treasuries and agencies

 

42,348 

 

 -

 

42,348 

 

 

Short-term investments available for sale:

 

 

 

 

 

 

 

 

Corporate bonds

 

91,028 

 

 -

 

91,028 

 

 -

U.S. treasuries and agencies

 

12,496 

 

 -

 

12,496 

 

 

Time deposits

 

1,760 

 

1,760 

 

 -

 

 -

Derivatives

 

5,665 

 

 -

 

5,665 

 

 -

Total Assets 

$

169,248 

$

17,711 

$

151,537 

$

 -



 

 

 

 

 

 

 

 

10


 

Liabilities

 

 

 

 

 

 

 

 

Derivatives

$

(7,371)

$

 -

$

(7,371)

$

 -

Total Liabilities 

$

(7,371)

$

 -

$

(7,371)

$

 -



 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

(In thousands)

 

Fair Value Measurements at Reporting Date Using

Description

 

December 31, 2016

 

Quoted Prices in Active Markets for Identical Assets (Level 1)

 

Significant Other Observable Inputs (Level 2)

 

Significant Unobservable Inputs (Level 3)

Assets

 

 

 

 

 

 

 

 

Cash and cash equivalents available for sale:

 

 

 

 

 

 

 

 

Money Market Funds

$

68,577 

$

68,577 

$

 -

$

 -

Short-term investments available for sale:

 

 

 

 

 

 

 

 

Corporate bonds

 

71,357 

 

 -

 

71,357 

 

 -

Time deposits

 

1,760 

 

1,760 

 

 -

 

 -

Derivatives

 

15,113 

 

 -

 

15,113 

 

 -

Total Assets 

$

156,807 

$

70,337 

$

86,470 

$

 -



 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

Derivatives

$

(8,199)

$

 -

$

(8,199)

$

 -

Total Liabilities 

$

(8,199)

$

 -

$

(8,199)

$

 -



We value our available-for-sale short-term investments based on pricing from third party pricing vendors, who may use quoted prices in active markets for identical assets (Level 1 inputs) or inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs) in determining fair value. We classify all of our fixed income available-for-sale securities as having Level 2 inputs. The valuation techniques used to measure the fair value of our financial instruments having Level 2 inputs were derived from non-binding market consensus prices that are corroborated by observable market data, quoted market prices for similar instruments, or pricing models, such as discounted cash flow techniques. We believe all of these sources reflect the credit risk associated with each of our available-for-sale short-term investments. Short-term investments available-for-sale consists of debt securities issued by states of the U.S. and political subdivisions of the U.S., corporate debt securities and debt securities issued by U.S. government organizations and agencies. All of our short-term investments available-for-sale have contractual maturities of less than 60 months.  

  

Derivatives include foreign currency forward and option contracts. Our foreign currency forward contracts are valued using an income approach (Level 2) based on the spot rate less the contract rate multiplied by the notional amount. Our foreign currency option contracts are valued using a market approach based on the quoted market prices which are derived from observable inputs including current and future spot rates, interest rate spreads as well as quoted market prices of similar instruments. We consider counterparty credit risk in the valuation of our derivatives. However, counterparty credit risk did not impact the valuation of our derivatives during the six month period ended June 30, 2017. There were no transfers in or out of Level 1 or Level 2 during the six month period ended June 30, 2017.  

  

As of June 30, 2017, our short-term investments did not include sovereign debt from any country other than the United States. 

  

We did not have any items that were measured at fair value on a nonrecurring basis at June 30, 2017 and December 31, 2016. The carrying value of net accounts receivable, accounts payable, and long-term debt contained in the Consolidated Balance Sheets approximates fair value.

 

Note 5 – Derivative instruments and hedging activities  

  

We recognize all of our derivative instruments as either assets or liabilities in our statement of financial position at fair value. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and further, on the type of hedging relationship. For those derivative instruments that are designated and qualify as hedging instruments, we designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation.

   

11


 

We have operations in over 50 countries. Sales outside of the Americas accounted for approximately 62% and 63% of our net sales during the three month periods ended June 30, 2017 and 2016, respectively, and approximately 61% and 62% of our net sales during the six month periods ended June 30, 2017 and 2016, respectively. Our activities expose us to a variety of market risks, including the effects of changes in foreign currency exchange rates. These financial risks are monitored and managed by us as an integral part of our overall risk management program.   

  

We maintain a foreign currency risk management strategy that uses derivative instruments (foreign currency forward and purchased option contracts) to help protect our earnings and cash flows from fluctuations caused by the volatility in currency exchange rates. Movements in foreign currency exchange rates pose a risk to our operations and competitive position, in that exchange rate changes may affect our profitability and cash flow, and the business or pricing strategies of our non-U.S. based competitors.

   

The vast majority of our foreign sales are denominated in the customers’ local currency. We purchase foreign currency forward and option contracts as hedges of forecasted sales that are denominated in foreign currencies and as hedges of foreign currency denominated financial assets or liabilities. These contracts are entered into to help protect against the risk that the eventual dollar-net-cash inflows resulting from such sales or firm commitments will be adversely affected by changes in exchange rates. We also purchase foreign currency forward contracts as hedges of forecasted expenses that are denominated in foreign currencies. These contracts are entered into to help protect against the risk that the eventual dollar-net-cash outflows resulting from foreign currency operating and cost of sales expenses will be adversely affected by changes in exchange rates.

   

We designate foreign currency forward and purchased option contracts as cash flow hedges of forecasted net sales or forecasted expenses. In addition, we hedge our foreign currency denominated balance sheet exposures using foreign currency forward contracts that are not designated as hedging instruments. None of our derivative instruments contain a credit-risk-related contingent feature.

 

  Cash flow hedges  



  To help protect against the reduction in value caused by a fluctuation in foreign currency exchange rates of forecasted foreign currency cash flows resulting from international sales over the next one to three years, we have instituted a foreign currency cash flow hedging program. We hedge portions of our forecasted net sales and forecasted expenses denominated in foreign currencies with forward and purchased option contracts. For forward contracts, when the dollar strengthens significantly against the foreign currencies, the change in the present value of future foreign currency cash flows may be offset by the change in the fair value of the forward contracts designated as hedges. For option contracts, when the dollar strengthens significantly against the foreign currencies, the change in the present value of future foreign currency cash flows may be offset by the change in the fair value of the option contracts net of the premium paid designated as hedges. Our foreign currency purchased option contracts are purchased “at-the-money” or “out-of-the-money.” We purchase foreign currency forward and option contracts for up to 100% of our forecasted exposures in selected currencies (primarily in Euro, Japanese yen, Hungarian forint, British pound, Malaysian ringgit and Chinese yuan) and limit the duration of these contracts to 40 months or less.  



For derivative instruments that are designated and qualify as a cash flow hedge, the effective portion of the gain or loss on the derivative is reported as a component of accumulated other comprehensive income (“OCI”) and reclassified into earnings in the same line item (net sales, operating expenses, or cost of sales) associated with the forecasted transaction and in the same period or periods during which the hedged transaction affects earnings. Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in current earnings or expenses during the current period and are classified as a component of “net foreign exchange gain (loss).” Hedge effectiveness of foreign currency forwards and purchased option contracts designated as cash flow hedges are measured by comparing the hedging instrument’s cumulative change in fair value from inception to maturity to the forecasted transaction’s terminal value.   



We held forward contracts with the following notional amounts:



 

 

 

 



 

 

 

 

(In thousands)

 

US Dollar Equivalent



 

As of June 30, 2017

 

As of December 31,



 

(Unaudited)

 

2016

Chinese yuan

$

41,860 

$

27,414 

Euro

 

137,059 

 

123,522 

Japanese yen

 

30,334 

 

44,982 

Hungarian forint

 

55,671 

 

57,077 

Malaysian ringgit

 

36,513 

 

42,510 

Total forward contracts notional amount

$

301,437 

$

295,505 

  

The contracts in the foregoing table had contractual maturities of 36 months or less at June 30, 2017 and December 31, 2016.  

12


 

  

At June 30, 2017, we expect to reclassify $0.7 million of losses on derivative instruments from accumulated OCI to net sales during the next twelve months when the hedged international sales occur, $0.3 million of losses on derivative instruments from accumulated OCI to cost of sales during the next twelve months when the cost of sales are incurred and $0.3 million of losses on derivative instruments from accumulated OCI to operating expenses during the next twelve months when the hedged operating expenses occur. Expected amounts are based on derivative valuations at June 30, 2017. Actual results may vary materially as a result of changes in the corresponding exchange rates subsequent to this date.  

  

The gains and losses recognized in earnings due to hedge ineffectiveness were not material for each of the six month periods ended June 30, 2017 and 2016 and are included as a component of net income under the line item “net foreign exchange gain (loss).”



Other Derivatives  

Other derivatives not designated as hedging instruments consist primarily of foreign currency forward contracts that we use to hedge our foreign denominated net receivable or net payable positions to help protect against the change in value caused by a fluctuation in foreign currency exchange rates. We typically attempt to hedge up to 90% of our outstanding foreign denominated net receivables or net payables and typically limit the duration of these foreign currency forward contracts to approximately 120 days or less. The gain or loss on the derivatives as well as the offsetting gain or loss on the hedge item attributable to the hedged risk is recognized in current earnings under the line item “net foreign exchange gain (loss).” As of June 30, 2017 and December 31, 2016, we held foreign currency forward contracts with a notional amount of $46 million and $60 million, respectively.   

13


 

The following tables present the fair value of derivative instruments on our Consolidated Balance Sheets at June 30, 2017 and December 31, 2016, respectively.   



 

 

 

 

 

 



 

 

 

 

 

 



Asset Derivatives



June 30, 2017

December 31, 2016

(In thousands)

(Unaudited)

 

 

 



 

 

 

 

 

 



Balance Sheet Location

 

Fair Value

Balance Sheet Location

 

Fair Value

Derivatives designated as hedging instruments

 

 

 

 

 

 

Foreign exchange contracts - ST forwards

Prepaid expenses and other current assets

$

3,014 

 

$

9,378 

 

 

 

 

 

 

 

Foreign exchange contracts - LT forwards

Other long-term assets

 

2,427 

 

 

3,866 

Total derivatives designated as hedging instruments

 

$

5,441 

 

$

13,244 

 

 

 

 

 

 

 

Derivatives not designated as hedging instruments

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange contracts - ST forwards

Prepaid expenses and other current assets

$

224 

 

$

1,869 

Total derivatives not designated as hedging instruments

 

$

224 

 

$

1,869 

 

 

 

 

 

 

 

Total derivatives

 

$

5,665 

 

$

15,113 



   



 

 

 

 

 

 



 

 

 

 

 

 



 

 

 

 

 

 



Liability Derivatives



June 30, 2017

December 31, 2016

(In thousands)

(Unaudited)

 

 

 



 

 

 

 

 

 



Balance Sheet Location

 

Fair Value

Balance Sheet Location

 

Fair Value

Derivatives designated as hedging instruments

 

 

 

 

 

 

Foreign exchange contracts - ST forwards

Accrued expenses and other liabilities

$

(4,343)

 

$

(4,672)



 

 

 

 

 

 

Foreign exchange contracts - LT forwards

Other long-term liabilities

 

(2,304)

 

 

(3,352)

Total derivatives designated as hedging instruments

 

$

(6,647)

 

$

(8,024)



 

 

 

 

 

 

Derivatives not designated as hedging instruments

 

 

 

 

 

 



 

 

 

 

 

 

Foreign exchange contracts - ST forwards

Accrued expenses and other liabilities

$

(724)

 

$

(175)

Total derivatives not designated as hedging instruments

 

$

(724)

 

$

(175)



 

 

 

 

 

 

Total derivatives

 

$

(7,371)

 

$

(8,199)



14


 

The following tables present the effect of derivative instruments on our Consolidated Statements of Income for three month periods ended June 30, 2017 and 2016, respectively:





 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

June 30, 2017

(In thousands)

(Unaudited)

Derivatives in Cash Flow Hedging Relationship

 

Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)

Location of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)

 

Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)

Location of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion)

 

Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion)

Foreign exchange contracts - forwards and options

$

(9,488)

Net sales

$

669 

Net foreign exchange gain/(loss)

$

-  



 

 

 

 

 

 

 

 

Foreign exchange contracts - forwards and options

 

3,171 

Cost of sales

 

(428)

Net foreign exchange gain/(loss)

 

-  



 

 

 

 

 

 

 

 

Foreign exchange contracts - forwards and options

 

2,795 

Operating expenses

 

(416)

Net foreign exchange gain/(loss)

 

-  

Total

$

(3,522)

 

$

(175)

 

$

-  







 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

June 30, 2016

(In thousands)

(Unaudited)

Derivatives in Cash Flow Hedging Relationship

 

Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)

Location of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)

 

Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)

Location of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion)

 

Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion)

Foreign exchange contracts - forwards and options

$

2,764 

Net sales

$

(904)

Net foreign exchange gain/(loss)

$

 -



 

 

 

 

 

 

 

 

Foreign exchange contracts - forwards and options

 

(1,442)

Cost of sales

 

(382)

Net foreign exchange gain/(loss)

 

 -



 

 

 

 

 

 

 

 

Foreign exchange contracts - forwards and options

 

(1,184)

Operating expenses

 

(360)

Net foreign exchange gain/(loss)

 

 -

Total

$

138 

 

$

(1,646)

 

$

 -







 

 

 

 

 

(In thousands)

 

 

 

 

 

Derivatives not Designated as Hedging Instruments

Location of Gain (Loss) Recognized in Income

 

Amount of Gain (Loss) Recognized in Income

 

Amount of Gain (Loss) Recognized in Income



 

 

June 30, 2017

 

June 30, 2016



 

 

(Unaudited)

 

(Unaudited)

Foreign exchange contracts - forwards

Net foreign exchange gain/(loss)

$

(632)

 

2,063 



 

 

 

 

 

Total

 

$

(632)

$

2,063 

15


 

The following tables present the effect of derivative instruments on our Consolidated Statements of Income for the six month periods ended June 30, 2017 and 2016, respectively:





 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

June 30, 2017

(In thousands)

(Unaudited)

Derivatives in Cash Flow Hedging Relationship

 

Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)

Location of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)

 

Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)

Location of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion)

 

Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion)

Foreign exchange contracts - forwards and options

$

(14,797)

Net sales

$

2,749 

Net foreign exchange gain/(loss)

$

 -



 

 

 

 

 

 

 

 

Foreign exchange contracts - forwards and options

 

4,480 

Cost of sales

 

(978)

Net foreign exchange gain/(loss)

 

 -



 

 

 

 

 

 

 

 

Foreign exchange contracts - forwards and options

 

3,983 

Operating expenses

 

(979)

Net foreign exchange gain/(loss)

 

 -

Total

$

(6,334)

 

$

792 

 

$

 -







 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

June 30, 2016

(In thousands)

(Unaudited)

Derivatives in Cash Flow Hedging Relationship

 

Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)

Location of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)

 

Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)

Location of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion)

 

Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion)

Foreign exchange contracts - forwards and options

$

(276)

Net sales

$

(1,141)

Net foreign exchange gain/(loss)

$

 -



 

 

 

 

 

 

 

 

Foreign exchange contracts - forwards and options

 

1,597 

Cost of sales

 

(953)

Net foreign exchange gain/(loss)

 

 -



 

 

 

 

 

 

 

 

Foreign exchange contracts - forwards and options

 

2,244 

Operating expenses

 

(889)

Net foreign exchange gain/(loss)

 

 -

Total

$

3,565 

 

$

(2,983)

 

$

 -









 

 

 

 

 

(In thousands)

 

 

 

 

 

Derivatives not Designated as Hedging Instruments

Location of Gain (Loss) Recognized in Income

 

Amount of Gain (Loss) Recognized in Income

 

Amount of Gain (Loss) Recognized in Income



 

 

June 30, 2017

 

June 30, 2016



 

 

(Unaudited)

 

(Unaudited)

Foreign exchange contracts - forwards

Net foreign exchange gain/(loss)

$

(3,178)

 

(191)

 

 

 

 

 

 

Total

 

$

(3,178)

$

(191)











16


 

Note 6 – Inventories, net 

  

Inventories, net consist of the following: 





 

 

 

 



 

June 30, 2017

 

December 31,

(In thousands)

 

(Unaudited)

 

2016



 

 

 

 

Raw materials  

$

93,345 

$

92,906 

Work-in-process

 

7,805 

 

9,125 

Finished goods

 

85,005 

 

91,577